Skip to main content
FinSpry Logo
FinSpry
PSTV logo
PSTV
(NASDAQ)
Plus Therapeutics, Inc.
$3.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Plus Therapeutics (PSTV) Stock Price & Financial Analysis

Plus Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.77 - $3.96
52-Week High$15.33
52-Week Low$0.39
Open$3.78
Volume67.47K
Average Volume (3M)109.38K
Market Cap25.51M
Shares Outstanding6.65M
Price to Sales (P/S)4.92
Price to Book (P/B)2.13
EV/EBITDA-2.83
Revenue (TTM)5.18M
Net Income (TTM)-11.93M
Free Cash Flow (TTM)-21.72M
EPS (TTM)$-2.13
Profit Margin-230.24%
Operating Margin-364.36%
Return on Equity (ROE)-99.75%
Debt to Equity0.06
50-Day MA$4.38
200-Day MA$4.67
52-Week Change405.80%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Plus Therapeutics

What is the current stock price for PSTV?

As of the latest trading session, PSTV stock trades at $3.84. The 52-week range is $0.39–$15.33, with a day range of $3.77–$3.96.

What is the P/E ratio for PSTV?

The P/E ratio (Price-to-Earnings) for PSTV is shown in the Key Statistics section. This valuation metric helps compare Plus Therapeutics, Inc. to industry peers.

Does PSTV pay dividends?

Plus Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PSTV?

Based on 1 analyst, the consensus for PSTV is Buy.

What is the market cap of PSTV?

Plus Therapeutics's market capitalization is $25.5M, classifying it as a micro-cap company. Plus Therapeutics operates in the Healthcare sector within the Biotechnology industry.